Drugs / Dapagliflozin Propanediol Hydrate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT05686616 Comparator | Apr 2022 → Apr 2024 | tricuspid valve insufficiency | Samsung Medical Center | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dapagliflozin Propanediol Hydrate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05686616 ↗ |